Faculty Information - Takuro Yukawa

Present specialized field

Journal

Presentation

（Last updated : 2021-07-28 15:56:02）

Takuro Yukawa
Department Kawasaki Medical School Kawasaki Medical School, Department of General Surgery,

Position Assistant Professor

■ Present specialized field

Cardiovascular surgery

■ Journal

1.	2017/02	A Case of Cholesterol Crystal Embolization with Hemorrhagic Imntestinal Ulcer
2.	2017/02	Evaluation of intra-ductal cancer spread using contrast superb micro-vascular imaging(SMI)-a case report-
3.	2016/10	A Case of Birt-Hogg-Dube (BHD) Syndrome Harboring a novel Folliculin (FLCN ) Gene mutation.
4.	2016/06	Pneumatosis intestinalis after gefitinib therapy for pulmonary adenocarcinoma: a case report.
5.	2016/03	MHC class I chain-related molecule A and B expression is upregulated by cisplatin and associated with good prognosis in patients with non-small-cell lung cancer
6.	2015/12	Lapatinib enhances trastuzumab-mediated antibody-dependent cellular cytotoxicity via upregulation of HER2 in malignant mesothelioma cells.
7.	2015/10	Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells
8.	2015/09	Prognostic nutritional index before adjuvant chemotherapy predicts chemotherapy compliance and survival among patients with non-small cell lung cancer
9.	2015/08	Clinical significance of dual-time-point 18F-FDG PET imaging in resectable non-small cell lung cancer.
10.	2015/06	Skin Tube Reconstruction for Esophageal Defects due to Postoperative Complications: Applying a skin flap in esophageal resection and reconstruction
11.	2015/02	Cyclooxygenase-2 expression is a prognostic biomarker for non-small cell lung cancer patients treated with adjuvant platinum-based chemotherapy.
12.	2015/01	Cyclooxygenase-2 genetic variants influence intratumoral infiltration of Foxp3-positive regulatory T cells in non-small cell lung cancer.
13.	2014/11	Difference in prognostic values of maximal standardized uptake value on fluorodeoxyglucose-positron emission tomography and cyclooxygenase-2 expression between lung adenocarcinoma and squamous cell carcinoma.
14.	2014/04	A case report of intrapulmonary schwannoma.
15.	2014	Clinical significance of vascular endothelial growth factor and Delta-like ligand 4 in small pulmonary adenocarcinoma
16.	2013/12	Lung cancer with sarcoid reaction in the lymph nodes following chemoradiotherapy
17.	2013/11	Case of pleural metastasis of prostate cancer.
18.	2013/11	Heterogeneity of the EGFR mutation status between the primary tumor and metastatic lymph node and the sensitivity to EGFR tyrosine kinase inhibitor in non-small cell lung cancer
19.	2013/09	Unknown primary large cell neuroendocrine carcinoma (LCNEC) in the mediastinum.
20.	2013/01	Influence of vascular endothelial growth factor single nucleotide polymorphisms on non-small cell lung cancer tumor angiogenesis
21.	2013	CT, MRI, and 18F-FDG PET-CT findings of pulmonary benign metastasizing leiomyoma: A case report
22.	2012/12	Successful Two-Stage Surgical Treatment for Lung Cancer in a Patient with Contralateral Giant Emphysematous Bullae
23.	2012/09	Characteristics of Non-Small Cell Lung Cancer Located in the Right Middle Lobe According to a Retrospective Study of Recurrence and Prognosis
24.	2012/07	Membrane-bound Estrogen Receptor-alpha Expression and Epidermal Growth Factor Receptor Mutation are Associated with a Poor Prognosis in Lung Adenocarcinoma Patients
25.	2012/02	Maximal Standardized Uptake Value on FDG-PET Is Correlated With Cyclooxygenase-2 Expression in Patients With Lung Adenocarcinoma
26.	2011/10	Interstitial lung disease after re-administration of gefitinib in a responder with no adverse effects during the first administration: a case report
27.	2010/11	A case of simultaneous lung cancer and abdominal aortic aneurysm treated with a two-stage strategy
28.	2010/10	Induction Chemoradiation Therapy with Cisplatin plus Irinotecan Followed by Surgical Resection for Superior Sulcus Tumor
29.	2010/05	Tumor-Infiltrating Foxp3+ Regulatory T Cells are Correlated with Cyclooxygenase-2 Expression and are Associated with Recurrence in Resected Non-small Cell Lung Cancer
30.	2010/04	Pulmonary Apical Mass,the So-Called Pulmonary Apical Cap,in a 43-Year-Old Woman
31.	2008	Pappillary Fibroelastoma Developing from the Left Ventricular Septum
Display 5 items
Display all(31)

■ Presentation

1.	2017/09/11	Survival of non-small cell lung cancer patients predicted from expression of PD-L1, HLA class I and MICA/B on tumor cells （Poster notice，General）
2.	2017/04/03	Development of a novel targeted therapy for malignant mesothelioma carcinoma by a midkine inhibitor. （Poster notice）
3.	2015/12/19	Overexpression of NK cell-activating ligand MICA/B correlates with superior outcomes and might be a therapeutic target for chemo-immunotherapy in non-small-cell lung cancer. （Poster notice，General）
4.	2015/09/28	Lapatinib enhances trastuzumab-mediated antibody-dependent cellular cytotoxicity by upregulating HER2 in malignant pleural mesothelioma cells （Poster notice，General）
5.	2015/09/07	COX-2 Genetic Variants Influence Intratumoral Infiltration of Foxp-3-Positive Regulatory T Cells in Non-Small Cell Lung Cancer （Poster notice，General）
6.	2014/09/28	Cytotoxic anticancer drug enhances NK cell-mediated cytotoxicity via the DNA stress induced NKG2D ligands in non-small-cell lung cancer cells （Poster notice，General）
7.	2014/07/18	Cytotoxic drugs and EGFR tyrosine kinase inhibitor effect on NK cell cytotoxicity in non-small-cell lung cancer cells （Poster notice，General）
8.	2013/10/30	EGFR signaling effects on NK cell-mediated cytotoxicity via NKG2D ligands-NKG2D interaction in non-small cell lung cancer cells （Speech，General）
9.	2013/09/28	Anticancer drugs effect on NK cell-mediated cytotoxicity via the regulation of NKG2D ligand expression in non-small cell lung cancer cells （Poster notice，General）
10.	2011/10/12	Biomarker Expression of Primary Non-small Cell Lung Cancer and Metastatic Lympn Nodes （Speech，General）
11.	2011/07/05	Correlation of the standardized uptake value in FDG-PET with the biological marker in lung adenocarcinoma less than 3cm （Poster notice，General）
12.	2011/07/05	Significance of Delta-like ligand 4 (DLL4) on the angiogenesis in non-small cell lung cancer （Poster notice）
13.	2009/11/01	Tumor-Infiltrating Foxp3+ Regulaory T Cells Are Correlated with Cyclooxygenese-2 Expression and are associated with Recurrence in Resected Non-Small Cell Lung Cance （Poster notice，General）
14.	2009/08/03	Tumor Infiltrating Foxp3+ Regulatory T Cells Are Correlated with Cyclooxygenese-2 Expression and Associated with Recurrence in Resected NSCLC （Poster notice，General）
15.	2009/08/01	Significance of vascular endothelial growth factor polymorphisms on the angiogenesis in non-small cell lung cancer （Poster notice，General）
16.	2008/10/28	Evaluation of Intermittent Claudication by Form PWV/ABI （Poster notice）
17.	2008/10/28	The Obturator Foramen Bypass in our Institution （Poster notice）
18.	2007/10/13	Late Outcome of Extra-anatomic Bypass for Infected Abdominal Aortic Aneurysm （Speech，General）
19.	2007/10/13	Three cases of total aortic replacement for Marfan Syndrome （Speech，General）
Display 5 items
Display all(19)